miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 20, 2026

Crypto News: Pepeto Crosses $10.13 Million While Bitcoin Price Prediction Targets $150,000 as Senate Votes to End Trump's Iran War

View original at globenewswire.com
“Over $10.13 million raised, stages closing in days, and addresses tied to large Bitcoin holders entering at a speed that says everything.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Crypto fund inflows hit $858 million last week, with Bitcoin products pulling $706 million and the largest weekly unwind of short positions in 2026

    60% confidence
  • Pepeto is the first presale to combine a zero-fee exchange, AI contract review, and staking returns as high as 172% APY

    60% confidence
  • Senate passed a war powers resolution 50-47 on May 19 with four Republicans joining Democrats to limit Trump's military operations in Iran

    60% confidence
  • On May 19, a tracked whale with $24.79 million in verified profits opened $21 million in longs across BTC, ETH, and DOGE

    60% confidence
  • Every trade on PepetoSwap generates buying pressure on the Pepeto token, the same model that lifted BNB from pennies to $1,369

    60% confidence
  • Xi Jinping offered to help end the Iran conflict at the China summit

    60% confidence
  • Bitcoin price prediction for 2026 sits at $150,000

    60% confidence
  • Pepeto was built by the cofounder of the Pepe ecosystem, who created a $7 billion token, alongside a developer from Binance

    60% confidence
  • Bitcoin could reach $200,000 if Iran tensions end

    60% confidence
  • Bitcoin trades at $77,070 on May 20, 2026

    60% confidence

Data points we hold from this source

Pepeto · cash10.13 USD
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com